113 related articles for article (PubMed ID: 23969084)
21. Radiosynthesis of 2'-deoxy-2'-[18F]-fluoro-5-methyl-1-beta-L-arabinofuranosyluracil ([18F]-L-FMAU) for PET.
Mukhopadhyay U; Pal A; Gelovani JG; Bornmann W; Alauddin MM
Appl Radiat Isot; 2007 Aug; 65(8):941-6. PubMed ID: 17517516
[TBL] [Abstract][Full Text] [Related]
22. Incidental Detection of Meningioma by 18F-FMAU PET/CT in a Patient With Suspected Prostate Cancer.
Varghese B; Velez E; Desai B; Jadvar H
Clin Nucl Med; 2018 Jul; 43(7):e245-e246. PubMed ID: 29742600
[TBL] [Abstract][Full Text] [Related]
23. In vivo measurement of cell proliferation in canine brain tumor using C-11-labeled FMAU and PET.
Conti PS; Bading JR; Mouton PP; Links JM; Alauddin MM; Fissekis JD; Ravert HT; Hilton J; Wong DF; Anderson JH
Nucl Med Biol; 2008 Jan; 35(1):131-41. PubMed ID: 18158952
[TBL] [Abstract][Full Text] [Related]
24. Correlation between radioactivity and chemotherapeutics of the (111)In-VNB-liposome in pharmacokinetics and biodistribution in rats.
Lee WC; Chang CH; Huang CM; Wu YT; Chen LC; Ho CL; Chang TJ; Lee TW; Tsai TH
Int J Nanomedicine; 2012; 7():683-92. PubMed ID: 22359447
[TBL] [Abstract][Full Text] [Related]
25. Rat studies comparing 11C-FMAU, 18F-FLT, and 76Br-BFU as proliferation markers.
Lu L; Samuelsson L; Bergström M; Sato K; Fasth KJ; Långström B
J Nucl Med; 2002 Dec; 43(12):1688-98. PubMed ID: 12468521
[TBL] [Abstract][Full Text] [Related]
26. A Pilot Trial Evaluating Zoledronic Acid Induced Changes in [
Vaishampayan UN; Tehrani OS; Lawhorn-Crews JM; Heilbrun LK; Dobson K; Smith D; Dickow B; Shields AF
Mol Imaging Biol; 2017 Dec; 19(6):810-816. PubMed ID: 28289967
[TBL] [Abstract][Full Text] [Related]
27. Imaging DNA synthesis in vivo with 18F-FMAU and PET.
Sun H; Mangner TJ; Collins JM; Muzik O; Douglas K; Shields AF
J Nucl Med; 2005 Feb; 46(2):292-6. PubMed ID: 15695789
[TBL] [Abstract][Full Text] [Related]
28. Phase I study of Doxil and vinorelbine in patients with advanced malignancies.
Laufman LR; Spiridonidis CH; Jones JJ; Rhodes V; Rossi K; Wallace K
Cancer Invest; 2004; 22(3):344-52. PubMed ID: 15493354
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic Efficacy Evaluation of Pegylated Liposome Encapsulated With Vinorelbine Plus
Chien YC; Chou YH; Wang WH; Chen JC; Chang WS; Tsai CW; Bau DT; Hwang JJ
Cancer Genomics Proteomics; 2020; 17(1):61-76. PubMed ID: 31882552
[TBL] [Abstract][Full Text] [Related]
30. Effects of capecitabine treatment on the uptake of thymidine analogs using exploratory PET imaging agents:
McHugh CI; Lawhorn-Crews JM; Modi D; Douglas KA; Jones SK; Mangner TJ; Collins JM; Shields AF
Cancer Imaging; 2016 Oct; 16(1):34. PubMed ID: 27751167
[TBL] [Abstract][Full Text] [Related]
31. Microwave-assisted one-pot radiosynthesis of 2'-deoxy-2'-[18F]fluoro-5-methyl-1-β-d-arabinofuranosyluracil ([18F]-FMAU).
Chen K; Li Z; Conti PS
Nucl Med Biol; 2012 Oct; 39(7):1019-25. PubMed ID: 22503457
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of pharmacokinetics of 111In-labeled VNB-PEGylated liposomes after intraperitoneal and intravenous administration in a tumor/ascites mouse model.
Lin YY; Li JJ; Chang CH; Lu YC; Hwang JJ; Tseng YL; Lin WJ; Ting G; Wang HE
Cancer Biother Radiopharm; 2009 Aug; 24(4):453-60. PubMed ID: 19694580
[TBL] [Abstract][Full Text] [Related]
33. Radiolabeled 2'-fluorodeoxyuracil-beta-D-arabinofuranoside (FAU) and 2'-fluoro-5-methyldeoxyuracil-beta -D-arabinofuranoside (FMAU) as tumor-imaging agents in mice.
Wang H; Oliver P; Nan L; Wang S; Wang Z; Rhie JK; Zhang R; Hill DL
Cancer Chemother Pharmacol; 2002 May; 49(5):419-24. PubMed ID: 11976837
[TBL] [Abstract][Full Text] [Related]
34. Sequential use of vinorelbine followed by gefitinib enhances the antitumor effect in NSCLC cell lines poorly responsive to reversible EGFR tyrosine kinase inhibitors.
Dal Bello MG; Alama A; Barletta G; Coco S; Truini A; Vanni I; Boccardo S; Genova C; Rijavec E; Biello F; Bottoni G; Sambuceti G; Grossi F
Int J Cancer; 2015 Dec; 137(12):2947-58. PubMed ID: 26089022
[TBL] [Abstract][Full Text] [Related]
35. Different modes of transport for 3H-thymidine, 3H-FLT, and 3H-FMAU in proliferating and nonproliferating human tumor cells.
Plotnik DA; Emerick LE; Krohn KA; Unadkat JD; Schwartz JL
J Nucl Med; 2010 Sep; 51(9):1464-71. PubMed ID: 20720049
[TBL] [Abstract][Full Text] [Related]
36. 3'-deoxy-3'-[18F]fluorothymidine as a new marker for monitoring tumor response to antiproliferative therapy in vivo with positron emission tomography.
Barthel H; Cleij MC; Collingridge DR; Hutchinson OC; Osman S; He Q; Luthra SK; Brady F; Price PM; Aboagye EO
Cancer Res; 2003 Jul; 63(13):3791-8. PubMed ID: 12839975
[TBL] [Abstract][Full Text] [Related]
37. Automated synthesis of 2'-deoxy-2'-[18F]fluoro-5-methyl-1-β-D-arabinofuranosyluracil ([18F]-FMAU) using a one reactor radiosynthesis module.
Li Z; Cai H; Conti PS
Nucl Med Biol; 2011 Feb; 38(2):201-6. PubMed ID: 21315275
[TBL] [Abstract][Full Text] [Related]
38. VEGF neutralizing antibody increases the therapeutic efficacy of vinorelbine for renal cell carcinoma.
Sinha S; Cao Y; Dutta S; Wang E; Mukhopadhyay D
J Cell Mol Med; 2010 Mar; 14(3):647-58. PubMed ID: 19017359
[TBL] [Abstract][Full Text] [Related]
39. Imaging a pancreatic carcinoma xenograft model with 11C-acetate: a comparison study with 18F-FDG.
Zhao C; Chen Z; Ye X; Zhang Y; Zhan H; Aburano T; Tian M; Zhang H
Nucl Med Commun; 2009 Dec; 30(12):971-7. PubMed ID: 19696689
[TBL] [Abstract][Full Text] [Related]
40. Structure-guided engineering of human thymidine kinase 2 as a positron emission tomography reporter gene for enhanced phosphorylation of non-natural thymidine analog reporter probe.
Campbell DO; Yaghoubi SS; Su Y; Lee JT; Auerbach MS; Herschman H; Satyamurthy N; Czernin J; Lavie A; Radu CG
J Biol Chem; 2012 Jan; 287(1):446-454. PubMed ID: 22074768
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
